Transmedics Group Inc
NASDAQ:TMDX
Operating Margin
Transmedics Group Inc
Operating Margin represents how efficiently a company is able to generate profit through its core operations.
Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.
Operating Margin Across Competitors
| Country | Company | Market Cap |
Operating Margin |
||
|---|---|---|---|---|---|
| US |
|
Transmedics Group Inc
NASDAQ:TMDX
|
4.1B USD |
11%
|
|
| US |
|
Abbott Laboratories
NYSE:ABT
|
234.5B USD |
17%
|
|
| US |
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
199.3B USD |
28%
|
|
| US |
|
Boston Scientific Corp
NYSE:BSX
|
157B USD |
19%
|
|
| US |
|
Stryker Corp
NYSE:SYK
|
149.9B USD |
22%
|
|
| IE |
|
Medtronic PLC
NYSE:MDT
|
110.7B USD |
19%
|
|
| DE |
|
Siemens Healthineers AG
XETRA:SHL
|
55.1B EUR |
14%
|
|
| US |
|
Becton Dickinson and Co
NYSE:BDX
|
49.7B USD |
13%
|
|
| US |
|
Edwards Lifesciences Corp
NYSE:EW
|
46B USD |
28%
|
|
| US |
|
IDEXX Laboratories Inc
NASDAQ:IDXX
|
41.8B USD |
29%
|
|
| CN |
|
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
|
274B CNY |
34%
|
Transmedics Group Inc
Glance View
TransMedics Group Inc. emerged as a pioneering force within the medical technology sphere, aiming to revolutionize the organ transplant landscape. Founded with the bold vision of enhancing the viability of donor organs, TransMedics has developed the Organ Care System (OCS) — a portable, medical device designed to keep human organs alive and functioning outside of the body. The OCS effectively mimics the internal conditions of a human body, providing a nurturing environment that maintains organs in a near-living state. This innovation helps extend the time that organs can be viably transplanted, thereby increasing the success rates of transplants and offering a lifeline to individuals on long waiting lists. Monetizing this groundbreaking technology, TransMedics operates primarily through sales of its OCS products and related consumables, catering to well-established transplant centers worldwide. The company also taps into service agreements and training packages, ensuring that their clients can maximize the use and benefits of their products with the highest proficiency. In doing so, TransMedics not only empowers surgeons and hospitals to perform more successful transplants but also strengthens its position as a leading provider in a niche yet critical market. By addressing the challenges of organ preservation and transportation, TransMedics creates a compelling business model rooted in providing invaluable solutions for the healthcare industry and, ultimately, improving patient outcomes on a global scale.
See Also
Operating Margin represents how efficiently a company is able to generate profit through its core operations.
Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.
Based on Transmedics Group Inc's most recent financial statements, the company has Operating Margin of 10.8%.
You don't have any saved screeners yet